News

Saturday, October 21 2023

Myasthenia Conference Sydney

Concord Hospital - Education Centre
9.00am to 4.30pm

(Parking available) 
“Attendance by Application”

June is International Myasthenia Gravis Awareness Month.
June Awareness month for Myasthenia Gravis is worldwide and MGAQ has organised through local
Councils and private organisations to “Light Up” landmarks in recognition of Myasthenia. Please go
and view these landmarks. Take a moment to reflect on your myasthenia journey. Capture the image
and share so myasthenia can gain more awareness in the community. This will help research. This
will help you with your myasthenia journey.
Brisbane – Friday 2nd June

Saturday, October 21 2023
 

MAA Myasthenia Conference, Sydney

“Attendance by Application”

ATAGI have recently released updated COVID booster advice for 2023 which has been accepted by the Government and includes availability of new bivalent vaccines. These contain both the original COVID-19 variant and also an updated vaccine against Omicron variant.
Overview:
•    ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) was 6 months ago or longer, and regardless of the number of prior doses received: 

MYASTHENIA GRAVIS ASSOCIATION OF QUEENSLAND INC.

PRESIDENT’S ANNUAL REPORT – YEAR ENDING 30 JUNE 2022

More good news about Mestinon supply improving for both 60mg and 180mg! The Mestinon supply shortage has been an evolving issue over the last few months and the MAA has been actively monitoring the situation and speaking with government and industry stakeholders to ensure we can access this important medication. We thank you for contacting us and your state associations with your feedback and we appreciate this has been concerning and sometimes frustrating. Please see the latest update below.  
 
180mg/Timespan 

Good news for the new year! The latest indication from iNova and via the TGA website is that the Mestinon 60mg supply shortage has been resolved sooner than expected.  

As per previous communications, the Myasthenia community are aware of the efforts being made by the MAA to bring about a re-established supply of Pyridostigmine/Mestinon medication for Australians. To further conversations with Industry and Government the MAA is looking for data about the amount of medications we require on a weekly basis.

MGAQ Christmas Function

to be held at 
Club Southside, 76 Mount Gravatt-Capalaba Rd, Upper Mt Gravatt
on Sunday, 11 December 11.30 am for 12 noon

For more information / RSVP
Contact Susan - Email: info@mgaq.org.au • Freecall 1800 802 568

The MAA continues to stay abreast of the Mestinon supply shortage issue and is in regular contact with government and industry stakeholders. The latest update for Timespan (180mg) and 60mg is below.